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Background: Glucose homeostasis is maintained by the processes of
glycolysis and gluconeogenesis. The importance of these pathways is
demonstrated by the severe and life threatening effects observed in various
forms of diabetes. The bifunctional enzyme 6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase catalyzes both the synthesis and degradation of fructose-
2,6-bisphosphate, a potent regulator of glycolysis. Thus this bifunctional enzyme
plays an indirect yet key role in the regulation of glucose metabolism.
Results:  We have determined the 2.0 Å crystal structure of the rat testis
isozyme of this bifunctional enzyme. The enzyme is a homodimer of 55 kDa
subunits arranged in a head-to-head fashion, with each monomer consisting of
independent kinase and phosphatase domains. The location of ATPgS and
inorganic phosphate in the kinase and phosphatase domains, respectively, allow
us to locate and describe the active sites of both domains.
Conclusions:  The kinase domain is clearly related to the superfamily of
mononucleotide binding proteins, with a particularly close relationship to the
adenylate kinases and the nucleotide-binding portion of the G proteins. This is in
disagreement with the broad speculation that this domain would resemble
phosphofructokinase. The phosphatase domain is structurally related to a family
of proteins which includes the cofactor independent phosphoglycerate mutases
and acid phosphatases.
Introduction
Glycolysis and gluconeogenesis in the liver are the primary
processes responsible for maintenance of glucose home-
ostasis. The profoundly debilitating effects observed in
diabetes mellitus underscore the importance of the accu-
rate maintenance of these processes. The b anomer of
fructose-2,6-bisphosphate (Fru-2,6-P2) is a key regulatory
molecule for glycolysis (and to some extent for gluconeo-
genesis) via its potent stimulatory effect on phospho-
fructokinase (PFK) activity and its inhibitory effect on
fructose-1,6-bisphosphatase (Fru-1,6-P2ase) [1–3]. 6-Phos-
phofructo-2-kinase (6-PF-2-K) synthesizes Fru-2,6-P2 from
fructose-6-phosphate (F6P) and ATP, while fructose-2,6-
bisphosphatase (Fru-2,6-P2ase) hydrolyzes Fru-2,6-P2 to
form F6P and inorganic phosphate (Pi). These antagonistic
activities reside in a single bifunctional enzyme, 6-phos-
phofructo-2-kinase/fructose-2,6-bisphosphatase (6-PF-2-K/
Fru-2,6-P2ase), which is found in the cytosol of all tissues
as a homodimer of ~56 kDa subunits. Homology of the
C-terminal half of the 6-PF-2-K/Fru-2,6-P2ase amino acid
sequence with that of the yeast phosphoglycerate mutase
[4], together with analysis of various truncated expression
constructs [1,5,6], showed the enzyme to be divided into
two functional domains. The N-terminal catalytic domain
houses the 6-PF-2-K activity, and the C-terminal domain
houses the Fru-2,6-P2ase activity.
Five mammalian isozymes of 6-PF-2-K/Fru-2,6-P2ase
have been discovered to date (isolated from liver, skeletal
muscle, heart, testis and brain,). The liver and skeletal
muscle isozymes arise by alternative splicing of a single
gene, while distinct genes encode the others [7–10]. The
muscle isozyme has the shortest N terminus, but retains
high 6-PF-2-K activity, and thus defines the N-terminal
border of the functional 6-PF-2-K domain (Fig. 1). The
other isozymes have N-terminal extensions which, in the
liver and testis enzymes, modulate enzyme activity [11].
The heart enzyme exists in two forms, differing by a
C-terminal extension which has a role in modulating the
activity of the enzyme [12].
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If the opposing activities of 6-PF-2-K/Fru-2,6-P2ase were
unregulated, this would lead to the futile cycling of sub-
strates, and the unproductive expense of ATP. To avoid
this, the 6-PF-2-K and Fru-2,6-P2ase activities of the
enzyme are intrinsically unequally balanced and modulated
by the concentrations of various metabolites (i.e. nucleotide
phosphates, F6P, phosphoenolpyruvate, citrate, Fru-2,6-P2,
phosphoglycerate, Pi and 6-phosphogluconate) [2,13]. For
example, at physiological concentrations of F6P (30–
40mM), the Fru-2,6-P2ase activity of the testis isozyme
should be inhibited (KiF6P is ~1mM). The activities of the
liver and heart isozymes are dramatically regulated by phos-
phorylation of their N- and C-terminal regulatory domains,
respectively [14,15]. The testis and muscle isozymes are
not phosphorylated by any protein kinases in vivo.
The N-terminal extensions of the liver and testis isozymes
are similar, with the major difference being a mutation in
the testis enzyme which destroys the recognition sequence
for the cAMP-dependent protein kinase (PKA). N-terminal
deletion mutations of the testis isozyme suggest that this
region modulates the 6-PF-2-K and Fru-2,6-P2ase activities,
and stabilizes the dimer form of the enzyme [11]. Removal
of the first 24 or 30 N-terminal amino acids of the testis
enzyme causes a protein concentration dependent dissocia-
tion of dimers to monomers, and a decrease in thermal sta-
bility and resistance to urea denaturation. These same
enzymes lose 70% of their 6-PF-2-K activity, while their
Fru-2,6-P2ase activity increases twofold. These kinetic
shifts are reminiscent of the effect of phosphorylation of the
liver enzyme N-terminal regulatory domain. This suggests
that phosphorylation of the liver enzyme may destabilize an
interaction of the N terminus with the remainder of the
protein.
The 6-PF-2-K/Fru-2,6-P2ase presented in this structural
study is a mutant of the rat testis isozyme [9]. This mutant
is one in a series of mutants in which the four tryptophan
residues in the isozyme were systematically mutated to
phenylalanine as part of a spectroscopic analysis study
[16]. Serendipitously, when all of the tryptophans were
replaced, the yield of protein from the Esherichia coli
expression system was dramatically increased, allowing for
the adequate production of protein for crystallization trials.
We report here the structure of this mutant rat testis 6-PF-
2-K/Fru-2,6-P2ase refined to 2.0 Å resolution. The rela-




Crystals of mutant rat testis 6-PF-2-K/Fru-2,6-P2ase
which diffract to high resolution (≥2.0 Å) were found in
the space group P3121 [17]. High resolution X-ray diffrac-
tion data were collected for both native and heavy atom
derivatized forms of the crystal as summarized in Table 1.
A typical course of multiple isomorphous replacement
(MIR), solvent flattening, model building, and refinement
were used in the structure solution (see Materials and
methods for details). The functional form of the protein is
a homodimer of 55k Da monomers. One monomer of the
protein is found in the crystallographic asymmetric unit,
with the dimer twofold rotation coincident with the crys-
tallographic twofold axis. The model has excellent geom-
etry and fits well in continuous electron density, with an
overall real space fit statistic of 0.93 for amino acids
37–468 (the C terminus). A portion of the 2Fo–Fc elec-
tron-density map is shown in Figure 2. The N-terminal 36
amino acids are not visible in the electron density. We
confirmed that the N terminus was intact in the crystals
by amino acid sequencing protein from the crystal that
was the source of the native data used for structure refine-
ment (Native 5). A summary of analyses of the overall
quality of the model are presented in Table 2. Only one
residue (Lys83) has F and ψ angles which are not within
the allowed region of a Ramachandran plot; this is
explained by the location of this residue near a switch
point in the structure which is apparently under strain
from crystal contacts.
Monomer structure
The 6-PF-2-K/Fru-2,6-P2ase monomer is clearly divided
into two functional domains as shown in Figures 3a–c. The
location of mutations which affect 6-PF-2-K activity
[18–21], and the localization of ATPgS in the structure,
identify the N-terminal domain as the 6-PF-2-K domain.
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Figure 1
Domain diagrams of the mammalian 6-PF-2-K/Fru-2,6-P2ase enzymes.
Serine and threonine (S,T) residues which are phosphorylated are
shown, as well as the location of the nucleotide-binding motif (nbf) in
the kinase domain, and the catalytic histidine (H) in the phosphatase
domain. The N-terminal extensions of the liver and testis isozymes and
the C-terminal extension of the heart1 isozyme have been shown to
modulate enzyme activity.
Sequence and structural homology with yeast phospho-
glycerate mutase [22] and rat acid phosphatase [23] (Fig.
3d), together with the location of mutations which affect
Fru-2,6-P2ase activity [24–28] suggested the C-terminal
domain to contain the Fru-2,6-P2ase activity. In further
support of this hypothesis, and most convincingly, the
expression of the C-terminal half of the protein in E. coli
demonstrated full Fru-2,6-P2ase activity [6], the C-terminal
domain is therefore clearly the Fru-2,6-P2ase domain. The
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Table 1
Data collection and MIR phasing statistics.
Native 1 Native 5 Thimerosal Me3PbOAc K2PtCl4
Data collection
Resolution (Å)  30–2.2  20–2.0  20–2.7  25–2.3  25–2.8 
Completeness* 98 (92) 90 (60) 95 (74) 88 (61) 86 (59)
Multiplicity    5.5 6.8 3.4 5.0 2.9
I/s(I)* 11.5 (3.7) 21.6 (2.7) 13.1 (1.9) 13.3 (5.1) 10.1 (1.5)
Rsym† 7.1 3.2 5.7 5.3 7.5
Wilson B 22.5 23.6 39.7 27.3 46.4
Riso‡ 25.0 24.8 23.9
MIR phasing (20–3.5 Å)
Soak (mM/h) 10/1.5 10/60 10/3
No. of sites 4 1 1
Total occupancy 2.9 0.9 0.8
Phasing power§ 1.2 1.0 0.45
Rcullis# 0.81 0.83 0.93
*I >s(I), the number in parentheses is the value in the high resolution
shell. †Rsym=Sh(Sj|Ij,h– <Ih>|/S Ij,h), where h = set of Miller indices and
j = set of observations of reflection h. ‡Riso=Sh||FDer|–|FNat||/Sh |FNat|,
where |FDer| = observed derivative structure factor amplitude and 
|FNat| = observed native structure factor amplitude. §Root mean square
(rms) fh/residual = √(Sfh2/S(FDer–FPH)2), where fh = calculated heavy-
atom structure factor, FPH = calculated derivative structure factor.
#Rcullis=S||fh|–(|FDer|–|FNat|)|/S||FDer|–|FNat||.
Figure 2
The final 2Fo–Fc electron-density map including data from 20–2.0 Å,
contoured at 1s above the mean for the entire map. The region shown
is the center of the b sheet which traverses the 6-PF-2-K dimer through




Resolution (Å) 6–2.0 20–2.0
Rwork (%) 18.3 20.6
Rfree (%) 25.0 27.2
No. of reflections (F≥s(F)) 29 479 30 655
Model
No. of amino acids 432/468*
No. of protein atoms 3 534
No. of heteroatoms 47
No. of water molecules 319







bond lengths (Å) 0.01 
bond angles (°) 1.55







Overall B factor (Wilson plot) 23.6
*Of the 468 expected amino acids 432 were modeled, the N-terminal
36 amino acids were not included in the structure.
6-PF-2-K domain consists of a central six-stranded b
sheet, with five parallel strands and an antiparallel edge
strand, surrounded by seven a helices (Fig. 3a,b). A
Walker A motif, or nucleotide-binding fold (nbf) [29,30] is
located at the C-terminal end of the first b strand (b1–3),
with the phosphates of a molecule of ATPgS bound in the
anion hole of the so-called phosphate-binding loop. The
Fru-2,6-P2ase domain is also a mixed a/b structure, with a
six-stranded central b sheet, plus an additional a-helical
subdomain that covers the presumed active site of the
molecule. In this structure the active site is occupied by
two phosphates (lower left in Fig. 3a).
Dimer interactions
The functional form of the enzyme is a dimer, with a single
monomer in the crystallographic asymmetric unit. As shown
in Figure 4, the monomers associate in a head-to-head
fashion with the 6-PF-2-K domains making intimate
contact, while the Fru-2,6-P2ase domains are essentially
independent. The 6-PF-2-K b sheet actually continues
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Figure 3
6-PF-2-K/Fru-2,6-P2ase monomer structure.
(a) Ribbon diagram of the 6-PF-2-K/Fru-2,6-
P2ase monomer with the 6-PF-2-K domain to
the right and the Fru-2,6-P2ase domain on the
left. a Helices are colored purple and labeled
a1–a15, b strands are in red, with one strand
of each sheet labeled. 310 Helices are colored
green, and random coil is in yellow. Ball-and-
stick models of the bound ATP in the
6-PF-2-K domain, and the two bound
phosphates in the Fru-2,6-P2ase domain are
also included. The helical subdomain of the
Fru-2,6-P2ase domain is at the lower left of
this view. (b,c) Topology diagrams for the
6-PF-2-K and Fru-2,6-P2ase domains;
a helices are represented as cylinders,
b strands as arrows. The two b sheets are
termed b1 and b2, the individual b strands
are numbered sequentially 1–6. The locations
of the ATP- and F6P-binding sites are
indicated. The lengths of the secondary
structure elements and the loops which
connect them are not drawn to scale.
(d) Sequence of the rat testis 6-PF-2-K/Fru-
2,6-P2ase protein. Locations of secondary
structure elements are underlined and labeled.
The locations of the Walker A (WA) and
Walker B (WB) motifs are also indicated [29].
The 6-PF-2-K domain extends from position
1–250, the Fru-2,6-P2ase domain extends
from position 251–468. 
across the twofold axis via an antiparallel b-strand inter-
action (Figs 2,4). This interaction extends the 6-PF-2-K
central b sheet to form a continuous twelve-stranded
intermonomer b sheet. In addition to this interaction at
the twofold axis, the a7 helices of the two monomers are
in contact, with several interdigitated side chains. Calcu-
lated differences in solvent accessible surface area in the
monomer and dimer forms of the enzyme, demonstrated
1867Å2 of surface area to be buried in the dimer interface,
distributed as shown in Table 3. Two thirds of the buried
area is located in the 6-PF-2-K/6-PF-2-K interface, imply-
ing that the enzyme evolved as a 6-PF-2-K homodimer,
with the largely independent Fru-2,6-P2ase domains teth-
ered to this 6-PF-2-K dimer.
Phosphorylation of an N-terminal subdomain regulates
both the 6-PF-2-K and Fru-2,6-P2ase activities of the liver
isozyme, while phosphorylation of the C-terminal subdo-
main of the heart isozyme regulates only the 6-PF-2-K
activity [14,15]. Truncation mutants at the N terminus of
the testis and liver isozymes also affect both the 6-PF-2-K
and Fru-2,6-P2ase activities [11,31]. These observations
have led to the proposal that the N and C termini are in
contact across the dimer interface (i.e. a head-to-tail dimer
arrangement) and thus both are positioned to achieve the
observed regulation [32,33]. The head-to-head arrangement
observed in the testis 6-PF-2-K/Fru-2,6-P2ase dimer, does
not support this explanation of these observations. Further-
more, the high degree of amino acid identity among the 
6-PF-2-K/Fru-2,6-P2ase isozymes virtually rules out the
possibility that the other isozymes form a different sort of
dimer arrangement than that observed in the testis isozyme.
The absence of the N-terminal subdomain from the model
of the testis enzyme does not offer any direct evidence for
how this subdomain regulates both the 6-PF-2-K and Fru-
2,6-P2ase activities. However, the location of the first
amino acid in the structure (Cys37), the length of the
missing segment (36 residues for the testis form, 39
residues by analogy for the liver isozyme), and the assump-
tion that it will adopt some independent fold, place limits
on the number of reasonable predictions of its location. A
first prediction would place the N-terminal subdomain
above helices a3 and a4 (lower right  in Fig. 3a), where it
would be close to the proposed F6P-binding site and could
cause the observed changes in KmF6P. However, this model
would not explain the positive effect of phosphorylation
on Fru-2,6-P2ase activity, as this location is at a distance
from the Fru-2,6-P2ase active sites (as evident in Fig. 4). A
second hypothesis would place the N-terminal subdomain
in the hinge region between the 6-PF-2-K and Fru-2,6-
P2ase domains. This could be achieved either as an intra-
monomer or intermonomer interaction. Such an interaction
would afford close contact with both domains, and an
obvious connection to 6-PF-2-K activity by proximity to
the ATP-binding site (Fig. 3a). This is also the location of
an interesting interaction between the 6-PF-2-K and Fru-
2,6-P2ase domains, in which the loop between b2–5 and
b2–6 (in the Fru-2,6-P2ase domain) comes quite close to
the ATP-binding site of the 6-PF-2-K domain (Fig. 3a).
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Table 3
Buried surface area in the dimer interface (monomers A and B).
6-PF-2-K (A) Fru-2,6-P2ase (A)
6-PF-2-K (B) 1253 212
Fru-2,6-P2ase (B) 212 190
All values given in Å2.
Figure 4
Arrangement of the functional dimer about the
crystallographic twofold axis of rotation. The
protein monomers are colored red and green,
and the ATPgS and PO4 ligands are in black.
(a) The rotation axis is vertical as shown here,
with a 180° rotation relating the red and green
monomers, it is clear that the Fru-2,6-P2ase
domains (the lower domains) are independent
of one another. Only a single salt bridge
interconnects the two domains. (b) This image
is obtained by rotating the dimer by ~15° about
a vertical axis. It is clear that the 6-PF-2-K
domains (the upper domains) are quite
intimately associated. A b-sheet interaction
persists across the dimer interface, generating
a 12-stranded b sheet through the dimer. This
b-sheet interaction at the dimer interface can
be seen just above and between the two
ATPgS molecules as seen in this picture.
An intermonomer interaction would explain the loss of
dimer stability in the mutant enzymes with N-terminal
truncations [11]. 
Regulation of the heart isozyme by phosphorylation of its
C-terminal subdomain is more of a mystery in light of this
structure. The heart isozyme has a significant (61 amino
acid) addition to its C terminus. In addition, in the testis
isozyme, the sites of phosphorylation by PKA and protein
kinase C (PKC) are located either within (in the case of
PKA) or quite near (in the case of PKC) the C terminus. If
the structure of the two isozymes were the same up to the
point of the heart isozyme C-terminal extension, the PKA
phosphorylation site would be coincident with the Pro465
residue in this structure. In fact, Pro465 is close to the
probable binding site for the 6-phosphate of Fru-2,6-P2
(~9Å from PO4 520, see below). This location does not fit
well with the experimental evidence however, as phos-
phorylation of the heart isozyme by PKA affects 6-PF-2-K
activity, with no effect on Fru-2,6-P2ase activity. However,
the sequence homology of the heart isozyme begins to
break down at position 451 of the testis isozyme, extend-
ing the potential size of the divergent C-terminal struc-
ture. Thus it seems likely that the C terminus of the heart
isozyme has a conformation and location that diverge from
the testis enzyme at or near position 451, and no reason-
able prediction of where this C-terminal subdomain might
be located can be made. 
The Fru-2,6-P2ase domain, and the phosphoglycerate
mutase family
As indicated above there is significant structural homol-
ogy between the Fru-2,6-P2ase domain and two families
of enzymes, the cofactor dependent phosphoglycerate
mutases [34], and the acid phosphatases [35]. The fold of
all three enzymes includes a central b sheet surrounded
by a helices (Fig. 3c), with an additional a-helical subdo-
main (consisting of two noncontiguous stretches of the
protein Glu325–Glu363 and  Thr443–Gln468, in the Fru-
2,6-P2ase domain). This subdomain acts as a lid over the
active site, and contributes side chains which are involved
in substrate binding. An optimized superposition (see
Material and methods) of the Fru-2,6-P2ase domain with
the structure of the yeast phosphoglycerate mutase [22]
yields a Ca root mean square (rms) deviation for 151 core
positions of 1.9 Å, and for the rat prostatic acid phos-
phatase [23], 110 core positions superimpose with an rms
of deviation of 2.0 Å.
These enzymes share a common catalytic mechanism
involving a covalent phosphohistidine intermediate [36–38]
located in a conserved sequence motif (Z-X-Arg-His-Gly-
Glu/Gln-X-X-X-Asn, where Z is a hydrophobic residue,
residues 255–262 in the Fru-2,6-P2ase domain). These con-
served amino acids are part of a larger conserved structural
motif which includes Arg305, Glu325, and His390, together
these residues define the catalytic center of all three
enzymes. Figures 5a–d show a diagram of the Fru-2,6-P2ase
reaction as proposed by Pilkis and coworkers [27] while
Figure 5e shows the catalytic center of the Fru-2,6-P2ase
domain. In the proposed Fru-2,6-P2ase reaction, the cat-
alytic histidine (His256) acts by nucleophilic attack on the
2-phosphate of Fru-2,6-P2. The side chains which are con-
served among the enzymes (Arg255, Asn262 and Arg305)
are proposed to orient Fru-2,6-P2 and stabilize the transi-
tion state. The second histidine (His390) is proposed to be
protonated, with the positive charge stabilizing the tran-
sient negative charge on the leaving group oxygen of the
transition state. The same histidine is also thought to act as
a general acid, protonating the leaving group. A water or
hydroxide then attacks the phosphoenzyme intermediate,
regenerating the enzyme and producing Pi. For the acid
phosphatases, the resolution of the phosphoenzyme inter-
mediate is also hydrolytic, while in the phosphoglycerate
mutases, phosphoglycerate acts as the nucleophile which
regenerates the enzyme, producing 2,3-diphosphoglycerate.
As shown in Figure 5e, two well ordered phosphates are
bound in the active site of the Fru-2,6-P2ase domain, one
bound to the catalytic histidine (PO4 510, the lower PO4 in
Fig. 5e), the other (PO4 520) is bound by side chains ema-
nating from the a-helical subdomain, occupying the proba-
ble binding site for the 6-phosphate of Fru-2,6-P2. The
spacing between these two phosphates is consistent with
several orientations of Fru-2,6-P2 modeled between them.
Despite kinetic evidence that F6P binds in the Fru-2,6-
P2ase active site, and the presence of F6P in the crystalliza-
tion, there is no electron density which can be clearly
interpreted as F6P in the Fru-2,6-P2ase active site of this
crystal structure. Mutagenesis studies in the liver isozyme
[26–28] have confirmed the importance to catalysis of
several residues neighboring PO4 510, including the cat-
alytic His256, and Arg255, Arg305, Glu325 and His390
(numbered 258, 257, 307, 327 and 392 in the liver isozyme).
In general, the interpretations of the mutagenesis results
are consistent with the structure, that is, that the basic
residues probably play a role in recruiting/binding the sub-
strate as well as stabilizing the transition state. Close exam-
ination of the relationship of His256 and PO4 510 shows
that the histidine Nε is directly in line with a P–O bond.
This observation is consistent with the proposed catalytic
mechanism involving an inversion of the phosphate geom-
etry on formation of the phosphohistidine intermediate
(see Fig. 5e). One conclusion is not supported by the struc-
ture, however. Lin et al. [27] have proposed that Glu325
acts to maintain His390 in a protonated state. However, in
the structure presented in Figure 5e Glu325 is not close
enough to His390 to support this conclusion. Instead,
Glu325 is acting to ‘cap’ the helix a14, and could only
interact with His390 if a structural rearrangement occurs on
substrate binding. The role that the conserved asparagine
(Asn262) might play in catalysis has not been addressed
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Figure 5
Schematic representation of the Fru-2,6-
P2ase reaction as proposed by Pilkis and co-
workers [27]. (a) The catalytic histidine
(His256) attacks the 2-phosphate of Fru-2,6-
P2. (b) The pentacoordinated transition state
is shown, stabilized by several salt bridges
and/or hydrogen bonds from side chains
which are not shown (Arg255, Arg305 and
Asn262). His390 is proposed to be
maintained in a protonated state by Glu325,
and this proton will be used in the resolution
of the transition state in favor of production of
the protonated F6P product. (c) The
phosphohistidine intermediate is shown, with
a water molecule in proximity. This water will
attack the phosphohistidine, generating Pi and
newly protonated His390 as shown in (d).
(e) Stereo view of the Fru-2,6-P2ase active
site. Phosphates are shown in ball-and-stick
representation with phosphorous atoms in
green, oxygens in red, and bonds in gray. The
lower phosphate as viewed here is bound in
the catalytic active site, adjacent to His256
which is the residue which forms the
phosphohistidine intermediate. The upper
phosphate is bound in the pocket which is
specific for the 6-phosphate of Fru-2,6-P2,
surrounded by several positively charged
residues (Lys354, Arg350 and Arg395). Side
chains which interact with the phosphates are
shown in ball-and-stick representation, with
oxygen atoms in red, nitrogen atoms in blue,
and carbon atoms and bonds in gray.
experimentally, but its proximity to PO4 510 would suggest
that it may also play a role in substrate recruitment or tran-
sition state stabilization. These issues await confirmation
by substrate analogue bound or product/transition state
mimic bound structures.
The binding site of PO4 520 (the upper PO4 in Fig. 5e)
has also been studied by mutagenesis of the liver isozyme
[24,25], and was implicated as the binding site for the
6-phosphate of Fru-2,6-P2 by mutations of Arg352, and
Lys356 (Arg350, Lys354 in the testis isozyme and Fig. 5e).
Other residues which are in contact with this phosphate
are Gln391, Tyr336, Tyr365 and Arg395, although their
role in substrate binding has not been tested experimen-
tally. One mutation which alters Fru-2,6-P2 binding
(Arg360 in the liver isozyme [24]) cannot be explained by
the structure, as the analogous Arg356 in the testis
isozyme is a solvent exposed residue, and not close to the
Fru-2,6-P2-binding site.
The crystal structure of a truncated rat liver Fru-2,6-P2ase
domain (amino acids 252–440 of the rat liver bifunctional
enzyme, analogous to 250–438 in the testis isozyme) was
recently reported [39]. The truncated liver Fru-2,6-P2ase
domain is in general quite similar to the testis Fru-2,6-
P2ase domain reported here, including a phosphate bound
in the active site, with analogous residues involved in phos-
phate coordination. No second phosphate was observed in
the presumed 6-phosphate-binding site of the liver
isozyme, but docking studies came to similar conclusions
(as described above) for the location and binding of the
phosphate as observed in the testis isozyme structure
reported here.
The most significant difference is the 30 amino acids
missing from the C terminus of the truncated liver Fru-2,6-
P2ase domain. This truncation has led to at least two signif-
icant differences between the structures. Firstly, the
absence of the C terminus has led to a much more open
active site than is seen in the testis isozyme. As described
by Lee et al. [39], the truncated liver domain has a funnel-
shaped active site, with the large end of the funnel
between two loops (260–273 and 328–357 in the liver
enzyme). The presence of the C terminus in a position
analogous to that seen for the testis isozyme would signifi-
cantly occlude this opening. The second apparent conse-
quence of the missing peptide is the formation of a dimer
of Fru-2,6-P2ase domains with C2 point group symmetry,
the asymmetric unit of the liver Fru-2,6-P2ase crystal. This
dimer interface coincides with the location of the C termi-
nus of the testis isozyme, and its presence in the liver
isozyme would preclude the formation of this dimer. Fur-
thermore, in contrast to the extended b-sheet interaction at
the dimer interface of the testis 6-PF-2-K domains
described above, the truncated liver Fru-2,6-P2ase domain
interface involves mainly side-chain interactions. We would
thus argue that the dimer observed in the intact testis
isozyme is the natural dimer, while that observed for the
liver Fru-2,6-P2ase domain is a consequence of the trunca-
tion of the C terminus.
The 6-PF-2-K domain, NMP kinases and G proteins
The binding of ATP by the 6-PF-2-K domain is very
much like that seen in other proteins which possess a
Walker A nbf (i.e. Gly-X-X-Gly-X-Gly-Lys-Thr, amino
acids 45–52 in the 6-PF-2-K domain). Table 4 summarizes
the nucleotide–protein interactions which are also dis-
played in Figure 6a. The N terminus of the a1 helix and
the main chain nitrogen atoms of residues 48–53 form an
anion hole that acts as a phosphate-binding pocket. In
addition, the conserved lysine residue of the nbf (Lys51)
interacts with both the b- and g-phosphates of ATP, in 
a position which is consistent with the proposal that it
remains bound to the g-phosphate during phosphoryl
transfer [30]. The conserved threonine of the nbf (Thr52),
and the conserved aspartate (Asp128) of the Walker B
motif (Z-Z-Z-Z-Asp, where Z is any hydrophobic residue)
provide two ligands for the octahedral Mg2+ ion (MG 501)
coordination; the b- and g-phosphates of ATP provide
another two ligands. The remaining two Mg2+ coordination
positions are not occupied.
The binding pocket for the nucleotide forms very few spe-
cific interactions with the polar groups of the adenine
moiety. The interactions mainly involve stacking between
the adenine rings and nonpolar side chains (Cys158, Val163,
Val220 and Val246). A single hydrogen bond is formed
between the Od oxygen of Asn167 and the adenine N6.
The substitution of a carbonyl at this position in a guanine
ring would still allow for this hydrogen bond after a simple
1024 Structure 1996, Vol 4 No 9
Table 4
ATP–protein interactions.
ATPgS atoms 6-PF-2-K/Fru-2,6-P2ase atoms 
Phosphates
Pg O1 K172 Nz, water 1005
O2 K51 Nz, water 1005
O3 Mg2+501, water 1003
Pb O1 R49 N, K51 N, K51 Nz
O2 T52 N, Mg2+501, water 1003, T52 Og2
O3 A48 N, K172 Nz
Pa O1 Y53 N
O2 K172 Nz, Y427 OH, water 1003
O3 G50 N
Ribose  
O3′ Q170 Ne2, N167 Nd2
ring plane Y53, N167
Adenine 
N3 N167 Od1
N6 water 664, water 693
ring plane V220, V246, main chain 49–50
180° exchange of the Asn167 Nd and Od atoms, leading to
an Nd–carbonyl interaction. This information predicts that
GTP should substitute freely for ATP as a phosphate donor
in the kinase reaction.
It has been speculated that the 6-PF-2-K domain resem-
bles  phosphofructokinase (PFK), and that the 6-PF-2-K
reaction proceeds with a mechanism similar to that of PFK
(i.e. a nucleophile, glutamate or aspartate, activates the
sugar hydroxyl group to potentiate its nucleophilic attack
on the g phosphate of ATP) [4,40]. Acting on this assump-
tion, and lacking any structural data, Uyeda and coworkers
produced a complete series of Glu/Asp→Ala mutants
(Uyeda et al., unpublished data) in the 6-PF-2-K domain.
Except for the aspartate residue that coordinates the ATP
associated Mg2+ ion (Asp128, Fig. 6), no mutant signifi-
cantly lowered the catalytic rate of the 6-PF-2-K reaction.
This result calls into question the exact catalytic mecha-
nism of the 6-PF-2-K reaction. Sequence analysis does not
predict any significant relation between the 6-PF-2-K
domain and other known proteins. However, examination
of the 6-PF-2-K fold reveals that this domain is structurally
related to the family of nucleoside monophosphate kinases
(NMP kinases) and to the catalytic core of the G proteins.
The calculated similarities of Ca positions in their cores
were: 1.9Å (for 102 residues of adenylate kinase [41]); 2.1Å
(for 129 residues of uridylate kinase UDK [42]); 1.5Å (for
52 residues of p21-Ras [43]); and 1.5Å (for 48 residues of
the G protein, Gia [44]). The catalytic centers are remark-
ably similar among the structures (shown in Fig. 6b). This
striking structural homology suggests there is a potential
similarity in their catalytic mechanisms, divergent from a
large group of nucleotide triphosphate phosphotransferases
in which a nucleophilic activation of the substrate is requi-
site for catalysis [45,46].
It has been proposed that the NMP kinases and the G pro-
teins catalyze their reactions by stabilization of the transi-
tion state, without a nucleophilic activation of the substrate
[41,42,44]. The convergent similarity of several catalytic
and structural residues from divergent regions of all three
structures (NMP kinases, G proteins and 6-PF-2-K) implies
that they may share this common catalytic mechanism. One
way of thinking about such a mechanism is to consider an
analogy with ATP/GTP hydrolysis in solution, in which a
transient negative charge must accumulate on the b–g
bridge oxygen during that transition state [47]. Relevant to
this mechanism is the superposition of Lys172 of the 6-PF-
2-K domain, Arg142 of yeast UDK, and Arg178 of Gia, as
shown in Figure 6b. These positively charged residues are
positioned so as to stabilize a negative charge on the b–g
bridge oxygen, and are not conserved among all nbf con-
taining proteins (i.e. EF-Tu, RecA and ADP ribosylation
factor). Furthermore, Arg178 of Gia was shown to be
recruited as a nucleotide contact residue only in the AlFl4-
transition state mimic complex [44]. This information, in
combination with the lack of a nucleophile near the pro-
posed active site described above, and the structural
homology with the NMP kinases and G proteins, make it
increasingly likely that the 6-PF-2-K reaction mechanism is
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Figure 6
Nucleotide–protein interactions of the 6-PF-
2-K domain. (a) Stereo view of ATPgS bound
in the 6-PF-2-K active site. Close contacts
between the ATPgS, Mg2+, Lys172, Lys51,
Thr52, and Asp128 are shown as white lines.
Also shown are Arg78, Arg79 and Arg193
residues which have been shown to affect
F6P binding. The multiple hydrogen bonds
formed between the phosphate oxygens and
the main chain nitrogens in the loop
connecting b1-1 and a1 are not shown.
(b) Stereo view of the superposition of the
6-PF-2-K (purple), the G protein Gia(orange),
and uridylate kinase (UDK) (turquoise) active
sites. The Gia coordinates are from the AlFl4–
transition state analogue structure [44], and
thus include the planar AlFl4– moiety shown in
yellow. The UDK structure includes two
bound ADP molecules, thus representing the
ADP–product complex [42]. The structures
were superimposed using only the protein
coordinates of the ATP-binding loops; this
results in an excellent superposition of the
6-PF-2-K g-phosphate, the Gia AlFl4–, and the
UDK product (b-phosphate). 
distinct from that of PFK. We propose that the 6-PF-2-K
domain operates via a transition state stabilization mecha-
nism alone, possibly with greater similarity to a dissociative
reaction mechanism than previously assumed. Confirma-
tion of this hypothesis will require further kinetic and
structural studies.
Another similarity between the 6-PF-2-K domain and the
NMP kinase structures is highlighted in Figure 7. The
NMP kinases have two mobile segments responsible for
ATP and substrate binding (shown in Fig. 7). These seg-
ments were initially identified in a series of adenylate
kinase (ADK) structures from different species [48], and
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Figure 7
The similarity of E. coli adenylate kinase ATP-
and AMP-binding loops to the proposed ATP-
and F6P-binding loops of the 6-PF-2-K
domain. Ribbon diagrams of the 6-PF-2-K
domain (purple) and E. coli adenylate kinase
(ADK) (green) in the substrate-bound (Ap5A)
and substrate-free (apo) conformations are
shown [41,49]. The mobile loops of ADK
involved in ATP and AMP (substrate) binding
are colored in white and yellow, respectively.
The 6-PF-2-K domain is presented in the
same orientation, with the proposed mobile
ATP- and F6P-binding loops also colored
white and yellow, respectively. In the absence
of substrates, the E. coli ADK ATP- and AMP-
binding loops are in an open conformation.
Ap5A is an inhibitor of E. coli ADK which
mimics both ATP and substrate. In the
presence of Ap5A, both binding loops of the
enzyme are in a closed conformation. The 6-
PF-2-K domain has bound ATP, and the ATP-
binding loop is in a closed conformation.
Despite the absence of F6P from the
structure, the F6P loop appears to be at least
partially closed, possibly due to crystal
contacts. 
Figure 8
Molecular surface representation of the 6-PF-
2-K domain in the vicinity of the catalytic
center. (a) The ATP-binding site of the
enzyme; in this view the ATP-binding loop is
above the ATP. The g-phosphate is partially
obscured by the surface of Lys172. There is a
predominant positive potential in the
phosphate-binding pocket of the enzyme.
Beyond the g-phosphate, a ‘hole’ through the
enzyme is plainly visible. This hole is
coincident with the proposed F6P-binding
site, and is formed at the interface between
the F6P-binding loop and the remainder of the
6-PF-2-K domain. (b) The 6-PF-2-K domain is
rotated in this view to look back towards the
ATP g-phosphate through the ‘hole’ in the
enzyme. The surfaces are color-coded for the
electrostatic potential at the surface, with the
most blue and red colors representing
potentials of +12 and –12 kcal, respectively.
The surfaces and potential maps were
generated in the absence of ATP. (Figure
generated by GRASP [61].)
more recently confirmed in a comparison of ligand-bound
and apo-ADK from E. coli [49]. The proposed function of
these mobile domains in the NMP kinases is to exclude
solvent from the vicinity of bound ATP to prevent futile
ATP hydrolysis. Analysis of temperature factors in our
structure shows that the 6-PF-2-K domain shares this flex-
ibility in analogous regions of its topology (Fig. 7). Thus
the segments of the 6-PF-2-K domain including amino
acids 74–100 and 159–194 have average Ca B factors of 34
and 36 respectively compared to an average Ca B factor of
26 for the remainder of the domain. By analogy to ADK,
these regions are predicted to be mobile segments which
trap F6P and ATP, respectively. In the 6-PF-2-K domain
the ATP-binding loop is closed, consistent with the fact
that the structure contains bound ATP. The F6P-binding
loop appears to be in a partially closed conformation
despite a lack of F6P in the binding site. In the crystal, the
conformations of both the ATP- and F6P- binding loops
may be stabilized in their observed positions by crystal
packing interactions. The theme of lobed structures with
probable induced fit changes on substrate/ATP binding
pervades the structures of other kinases as well, including
PFK [50], hexokinase [51], phosphoglycerate kinase [52],
and pyruvate kinase [53]. 
While it has not been possible to refine the position of a
molecule of F6P in the active site of the 6-PF-2-K domain,
there are clear indications as to where the F6P-binding site
is located. Firstly, the site-specific mutants which affect the
6-PF-2-K activity via an effect on KmF6P map to a single
region of the structure (Arg102, Arg193 and Arg136) [18–21]
(Uyeda et al., unpublished data). Secondly, this region is
coincident with the NMP-binding sites of the NMP
kinases, and is adjacent to the bound ATPgS. Finally, there
is residual electron density in this location, which cannot be
modeled as water. Based on these concordant pieces of cir-
cumstantial evidence, the binding site for F6P can be pre-
dicted with some confidence to be analogous to the
NMP-binding sites of the NMP kinases (Fig. 6b). As shown
in Figure 8, there is a ‘hole’ in the structure, at the interface
between the body of the 6-PF-2-K domain and the F6P-
binding loop, with an appropriately placed positive electro-
static potential to recruit and bind the negatively charged
6-phosphate of F6P.
Biological implications
Glycolysis is essential for energy production from
glucose and for the formation of the three carbon com-
pounds used as precursors for the synthesis of amino
acids, fatty acids, and cholesterol. The rate of glycolysis
in the liver is integral to the maintenance of blood
glucose levels. The importance of glucose homeostasis is
obviated by the various forms of diabetes where unregu-
lated glucose levels cause life-threatening results. Fruc-
tose-2,6-bisphosphate (Fru-2,6-P2) is the physiological
activator of phosphofructokinase (PFK), and hence the
cytosolic concentration of Fru-2,6-P2 regulates glycoly-
sis. In turn, the bifunctional enzyme 6-phosphofructo-
2-kinase/fructose-2,6-bisphosphatase (6-PF-2-K/Fru-2,6
-P2ase) controls the levels of Fru-2,6-P2, and thus the
activities of this enzyme are central to the control of 
glycolysis.
The crystal structure of 6-PF-2-K/Fru-2,6-P2ase con-
firms predictions that the kinase and phosphatase activi-
ties are found in separate domains. The Fru-2,6-P2ase
domain is a member of the phosphoglycerate mutase
family. Contrary to predictions that the 6-PF-2-K domain
would resemble PFK (6-PF-1-K), it is related to the
nucleotide monophosphate (NMP) kinases, and the cat-
alytic domain of G proteins. The fine structure of the
6-PF-2-K active site and its homology to these other pro-
teins imply that the 6-PF-2-K domain operates by transi-
tion state stabilization. This is in contrast to the PFK
mechanism, which involves a nucleophilic activation of
the Fructose-6-phosphate hydroxyl group. The 6-PF-2-K
domain has mobile ATP- and substrate-binding loops
analogous to those in the NMP kinases. 
This structure will lead to the design of specific experi-
ments to test the mechanisms of catalysis, and the coor-
dinate regulation of catalytic activities. It will also serve
as a good model for the catalytic domains of the remain-
ing isozymes, because of the high homology among
them. Ultimately, this structure may lead to the design of
novel therapeutic compounds to alter the rate of glycoly-
sis in the liver for treatment of type II diabetes, or in the
myocardium for intervention in ischemic heart disease.
Materials and methods
Crystallization and heavy atom derivatization
The W0 mutant (all tryptophans mutated to phenylalanine) of the rat
testis isozyme of 6-PF-2-K/Fru-2,6-P2ase was expressed in E. coli and
purified as described [11,16]. Crystals were prepared by sitting drop
vapor diffusion of 10 mgml–1 protein (in 50 mM Tris-PO4 pH 7.5, 5 %
glycerol, 0.5 mM EDTA, 1 % PEG 400, 10 mM DTT, 3 mM MgCl2, 1mM
ATPgS and 1 mM F6P) mixed 50 :50 with a well solution of 15 % PEG
4000, 50 mM succinate pH 6.2, 10 mM HEPES pH 7.0 and 2 % n-octyl-
glucoside, as previously reported [17]. Heavy-atom derivatives were pre-
pared by equilibrating crystals in a surrogate mother liquor (16 % PEG
4000, 50 mM succinate pH 6.2, 10 mM HEPES pH 7.0, 50 mM Tris-
PO4 pH 7.5, 5 % glycerol, 0.5 mM EDTA, 1 % PEG 400, 10 mM DTT
and 3 mM MgCl2) containing heavy atoms as listed in Table 1.
Data collection and processing
Crystals were prepared for flash freezing in liquid ethane by serial trans-
fers into solutions of surrogate mother liquor (see above) with increasing
concentrations of glycerol (10–25 % in 5 % steps). Crystals were main-
tained at 120°K in a dry nitrogen stream using a Molecular Structure
Corporation cryodevice. Data were collected on a Xuong-Hamlin multi-
wire area detector (Native 1, K2PtCl4 and Thimerosal derivatives) or on
an R-Axis II (Rigaku) image plate detection system (Native 5 and
Me3PbOAc derivative), both systems were mounted on Rigaku rotating-
anode generators and operated at 50mA, 100kV, with a graphite mono-
chromater, or 20mA, 100kV with double mirror focusing (Molecular
Structure Corporation), respectively. Xuong-Hamlin data were integrated
using the program XDS [54], R-Axis data using the program Denzo [55].
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All data were merged and scaled in Scalepack [55] and formatted for
subsequent use in either the CCP4 suite [56] or X-PLOR [57].
MIR phasing, model building and refinement
Potential heavy-atom derivative diffraction data were scaled to native
data using the Scaleit program in CCP4. Difference Patterson maps
and vector verification (RSPS in CCP4) immediately identified a single
heavy-atom site in the Me3PbOAc derivative. MLPHARE (CCP4) was
used to refine the position and occupancy of this site, and the resulting
SIR phases were then used to search for additional derivatives by dif-
ference Fourier analysis in conjunction with Patterson and vector verifi-
cation procedures. The handedness of the structure was determined,
and the three derivatives in Table 1 were refined (using the anomalous
dispersion data, in MLPHARE; MIR phases were calculated resulting in
a figure of merit of 0.53 for 20–3.5 Å data. The MIR phases were
improved by solvent flattening and histogram matching (calculated
solvent content 49 %, used 40 % in the program DM in CCP4).
Electron-density maps were calculated with these improved phases with
data from 20–3.5 Å, 20–3.0 Å and 20–2.8 Å, with the lowest resolution
map being the most interpretable. The 3.5 Å map was skeletonized, and
the skeleton used as a guide to build a Ca chain trace in the program O
(version 5.1) [58]. The Ca trace was then converted with the Lego_CA
command (O) to include 330 alanine residues in seven segments. This
partial structure was subjected to positional refinement in X-PLOR, and
the resulting partial structure phases were subsequently combined with
the MIR phases, using weights computed in SIGMAA [59]. In two further
similar rounds of model building, a continuous polypeptide was con-
structed, and side chain density was clear enough to unambiguously
place the amino acid sequence into the observed electron density for
amino acids 37–468. This initial model refined well in X-PLOR, extending
the resolution in steps from 3.5Å to 3.0Å, 2.5Å and 2.2Å, refining posi-
tions and individual B factors. Simulated annealing at 2.2Å and subse-
quent positional refinement yielded an Rwork of 27.0% and an Rfree of
38.6% for data from 6–2.2Å with F≥3(sF). Several rounds of model cor-
rection and refinement and the addition of ADP, Mg, two PO4 groups
and 60 water molecules yielded a model with an Rwork of 20.9 % and an
Rfree of 29.1%. At this point a higher resolution native data set was col-
lected, and the refinement proceeded against that data (Native 5, Table
1). Due to persistent density at a covalent distance from the ADP b-phos-
phate, a g-phosphate was added, and assigned an arbitrary reduced
occupancy (0.4). Despite the presence of 1mM F6P in the crystallization
mixture, no ordered F6P could be modeled in either the 6-PF-2-K or Fru-
2,6-P2ase active sites. There is residual density in both presumed F6P-
binding sites, but none of the possible interpretations of this density 
as F6P were refineable. We assume that the binding sites are partially
occupied by several orientations of F6P or some other competitor mol-
ecule(s). Some of this residual density was eventually modeled as water,
but difference density remains, indicating that some more electron dense
species occupy these binding sites. Addition of water molecules and an
ordered glycerol and further refinement yielded the final model reported
here (Table 2).
Structure comparisons
Structural superpositions were calculated with the lsq_explicit and
lsq_improve facilities within O [58]. Parameters for the superposition
were set so that only contiguous stretches of three or more residues
were included in the superposition. Atom pairs with an rms deviation
greater than 3.8 Å were excluded from the calculations.
Accession number
Coordinates are being deposited with the Protein Data Bank [60].
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